Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript
Cover image of the article: Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

Image Credit:Hepat Mon

Outline

Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

Authors

Seyed Moayed Alavian1,*, Ali Kabir2, Behzad Hajarizadeh2, Mohsen Nayebpour Pharm3, bashir hajibeigi2, Taher Doroudi2, F. E. Baralle4
1Baqiyatallah Hospital Tehran Hepatitis Center, Tehran, IR-Iran
2Methodology and statistics consultant Tehran Hepatitis Center, Tehran, IR-Iran
3Assistant professor of pharmacology, Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, IR-Iran
4Professor and Director of International Center for Genetic Engineering and Biotechnology, Trieste, Italy
*Corresponding Author: Baqiyatallah Hospital Tehran Hepatitis Center, Tehran, IR-Iran Email: alavian@thc.ir
Hepatitis Monthly:Vol. 4, issue 6; e92940
Published online:May 31, 2004
Article type:Research Article
Received:May 05, 2019
Accepted:May 31, 2004
How to Cite:Alavian SM, Kabir A, Hajarizadeh B, Nayebpour Pharm M, hajibeigi B, et al. Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C. Hepat Mon. 2004;4(6):e92940. doi:
KeywordsInterferonRibavirinHepatitis CTreatment

References

  • 1.
    The References are available in the PDF file.

Copyright

© 2004, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2006
Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Seyed Moayed Alavian,
Masoud Ahmadzad Asl,
maryam keshvari,
Bita Behnava,
bashir hajibeigi
PDF

Alavian SM, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. doi:

1
Jan
2006
Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

SM Alavian,
A Kabir,
B Hajarizadeh,
M Nayebpour,
T Dorodi,
FE Baralle
PDF

Alavian S, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, et al. Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study. Shiraz E-Med J. 2006;7(1):20390. doi:

30
Sep
2004
Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C

Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C

Mohammad Reza Zali,
Hamid Mohaghegh Shalmani,
Mohsen Norouzinia,
Amir Hooshang MohammadAlizadeh,
Azita Nowroozi,
Negar Behrouz
PDF

Zali M, Shalmani H, Norouzinia M, MohammadAlizadeh A, Nowroozi A, et al. Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C. Hepat Mon. 2004;4(7):. doi:

14
Dec
2013
Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

Zaigham Abbas,
Ghiasun Nabi Tayyab,
Mustafa Qureshi,
Mohammad Sadik Memon,
Amna Subhan,
Tanzila Shakir
,et al.
PDF

Abbas Z, Tayyab GN, Qureshi M, Memon MS, Subhan A, et al. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin. Hepat Mon. 2013;13(12):e14146. doi: https://doi.org/10.5812/hepatmon.14146

30
Sep
2004
Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Moayed Alavian,
Behzad Hajarizadeh,
Bashir Hajibeigi,
Taher Doroudi,
Amir Kambiz Hamadanizadeh,
Koroush Abar
PDF

Alavian S, Hajarizadeh B, Hajibeigi B, Doroudi T, Hamadanizadeh A, et al. Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian. Hepat Mon. 2004;4(7):. doi:

More by these authors

Seyed Moayed AlavianPubMedScholar
Ali KabirPubMedScholar
Behzad HajarizadehPubMedScholar
Mohsen Nayebpour PharmPubMedScholar
bashir hajibeigiPubMedScholar
Taher DoroudiPubMedScholar
F. E. BarallePubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF47.49 KB
Share
Cited by
Metrics
Comments
Number of Comments:0